BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220429
DTSTAMP:20260514T014735
CREATED:20220411T052608Z
LAST-MODIFIED:20220411T052647Z
UID:2700-1650931200-1651190399@thebiocalendar.com
SUMMARY:WuXi Healthcare Forum 2022
DESCRIPTION:Dear Colleagues and Friends\, \nJoin thousands from around the world virtually this April 26-28 for the complimentary global WuXi Healthcare Forum 2022 as our industry and R&D ecosystem converge to respond to the World Health Organization’s calls for urgent action to address Noncommunicable Diseases (NCD) – with cardiovascular diseases\, cancer\, and neurological disorders as the top challenges – which are collectively responsible for almost 70% of all deaths worldwide. \nA vital opportunity to take actions on topics that matter – \n• Rising to the Challenge: Why are the challenges facing our ecosystem so urgent? What’s holding us back from making new progress? How do we continue to break through barriers? AstraZeneca’s BioPharmaceuticals R&D Chief Sir Menelas Pangalos\, Director of NINDS/NIH\, Walter Koroshetz\, Chief Science & Medical Officer of American Heart Association\, Mariell Jessup\, CVCT Forum Chair\, Faiez Zannad\, Chief Patient Officer of American Cancer Society\, Arif Kamal\, CEO-Partner of Flagship Pioneering\, Stephen Hahn\, and J&J’s External Innovation Chief\, William Hait\, will share their perspectives and vision for the future. \n• Moving the Needle in Neurological Disorders: A dynamic VC roundtable featuring Laurence Barker of The Dementia Discovery Fund\, Philip Scheltens of the Dementia Fund at EQT Life Sciences\, Christina Isacson of Lightstone Ventures\, and Rana Al-Hallaq of Pfizer Ventures. \n• Spotlight on Parkinson’s Disease: To highlight Parkinson’s Disease Awareness Month this April\, we will showcase the unique challenges and opportunities facing the development of new therapeutics for PD’s with a dialogue between Todd Sherer of the Michael J. Fox Foundation and Andrew Siderowf of the University of Pennsylvania School of Medicine. \n• Revitalizing Cardiovascular R&D: What are the rate-limiting steps of CVD R&D? How can we move the dial on drug discovery & development towards finding a cure? Simone Fishburn\, Chief Editor of BioCentury will lead a C-suite roundtable with Sekar Kathiresan of Verve Therapeutics\, Claudia Ulbrich of Cardior Pharmaceuticals\, Christopher de Souza of Broadview Ventures\, and Michael Mendelsohn of Cardurion Pharmaceuticals. \n• Conquering the Next Frontiers in Cancer Therapies: How can we tackle difficult cancers? How do we breach the heterogeneity issue in cancer therapeutic development? Are we delivering on the promise of precision medicine for cancers? These and many more questions will be debated among a leading expert panel\, featuring Lewis Williams of Walking Fish Therapeutics\, Adam Friedman of Scorpion Therapeutics\, Luba Greenwood of Kojin Therapeutics\, Rajesh Chopra of Apple Tree Partners\, and KT Moortgat of Droia Ventures. \n• And more on new modalities\, new targets and new enabling platforms… \nComplimentary and open to the global healthcare innovation ecosystem\, this 3-day program will premiere via Zoom from 8 AM – 11 AM PDT (11 AM – 2 PM EDT) daily on April 26-28. \nClick HERE for our speaker bios and program agenda. \nGlobal challenges require global solutions and global collaborations. We hope you will join us for this year’s dynamic discussions. \nBest regards\, \nWuXi Healthcare Forum Committee
URL:https://thebiocalendar.com/event/wuxi-healthcare-forum-2022/
LOCATION:PA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220428T073000
DTEND;TZID=UTC:20220429T160000
DTSTAMP:20260514T014735
CREATED:20211228T232305Z
LAST-MODIFIED:20220415T182712Z
UID:2471-1651131000-1651248000@thebiocalendar.com
SUMMARY:Patients as Partners in Clinical Research
DESCRIPTION:The 9th annual Patients as Partners in Clinical Research is a 2-day festival of real-world examples from patients\, pharma and FDA on how patient involvement is implemented to drive greater efficiencies in clinical research. Each session demonstrates the what\, where\, when and how and measures the impact of those initiatives. \nKey Topic Areas:\n– Applying Patient Engagement Initiatives and Demonstrating Impact\n– Patient Input to Help R&D Obtain Better Outcomes from Clinical Research\n– FDA Guidance Updates and New Agency Efforts\n– Returning Data to Patients\n– Advancing Hybrid/Decentralized Clinical Trial Initiatives\n– Community Engagement & Building Trust to Ensure Diversity\, Equity and Inclusion in Clinical Research\n– Operationalizing Patient Engagement From Research Through to Commercialization\n– New Tools for Patient Experience Mapping\, Optimizing Digital Inclusion and Increasing Diversity and Inclusion in Clinical Trials\n– Collaborative Efforts for Reducing the Burden at the Site Level to Better Serve Patients \nPLUS….Interactive Sessions Including:\n– Hackathon on Patient-Centered Clinical Trial Solutions\n– Mapping Hybrid/DCT Opportunities in Medicines Development\n– Birds of a Feather Roundtable Discussions \nLearn more at www.patientsaspartners.org
URL:https://thebiocalendar.com/event/patients-as-partners-in-clinical-research/
LOCATION:PA
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2021/12/PatientsasPartners_Bio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220428T110000
DTEND;TZID=UTC:20220428T130000
DTSTAMP:20260514T014735
CREATED:20220415T181044Z
LAST-MODIFIED:20220415T181055Z
UID:2729-1651143600-1651150800@thebiocalendar.com
SUMMARY:Paving the Path to IPO: How to Build Compliant Financial Systems and Processes
DESCRIPTION:Whether you are a fast-growing biotech company or are currently public and looking for SOX compliance\, this webinar will cover how to set up scalable and compliant financial processes. \nGoing public is an exciting and significant milestone for any high-growth company. However\, some IPOs are delayed or even fail\, due to a lack of thorough planning. It’s a complicated process with lots of room for error and risks. \nPrior to going public\, your business must establish secure financial controls to demonstrate responsible financial stewardship and protect the shareholder. This includes supplier due diligence\, accurate record-keeping\, and employee spending thresholds. In addition to financial controls\, extreme growth can often lead to AP bottlenecks. \nAttend this webinar to hear real-life experiences and best practices on how to reduce risk\, build trust\, and increase transparency for decision-making\, by laying the right infrastructure and financial systems for sustainable\, long-term growth. \nKey Learning Objectives: \n\nBuilding scalable Business Spend Management (BSM) processes\nWhat the IPO process looks like and how you can best prepare\nHow to work with third-party auditors\nSOX compliance best practices\nRisk management\n\nWho Should Attend: \n\nFinance and Accounting Professionals\, Operations Professionals\, and IT Professionals
URL:https://thebiocalendar.com/event/paving-the-path-to-ipo-how-to-build-compliant-financial-systems-and-processes/
LOCATION:PA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220428T160000
DTEND;TZID=UTC:20220428T183000
DTSTAMP:20260514T014735
CREATED:20220425T191510Z
LAST-MODIFIED:20220517T235559Z
UID:2741-1651161600-1651170600@thebiocalendar.com
SUMMARY:SoCalBio Networking Forum
DESCRIPTION:Incubator vs Accelerator: What is more beneficial to a startup entrepreneurs\nJoin us to learn about and network with incubators in the Greater Los Angeles Metro Area that are fueling the growth of biotech and medtech entrepreneurial activities. The event will feature the following incubators and accelerators: \n\nLA Biospace (East Los Angeles)\nMagnify at UCLA (Westwood)\nNXT Biomedical (Irvine)\nPasadena Bio Collaborative (Pasadena)\nMurrieta Genomics (Murrieta)\nVentura BioCenter (Thousand Oaks)\nBioLabs at Lundquist Inst. (Torrance)\nULP at UCI (Irvine)\nOak Crest Institute (Monrovia)\n\n\n\nAgenda\n1:00 PM – 1:15 PM SoCalBio Introduction \n1:15 PM – 2:15 PM Incubator Panel \n2:15 PM – 3:15 PM Accelerators Panel \n3:15 PM – 3:25 PM Business Support Panel \nQ&A until the End of Showcase
URL:https://thebiocalendar.com/event/socalbio-networking-forum-2/
LOCATION:PA
END:VEVENT
END:VCALENDAR